Brief: Astrazeneca Pharma Says Bhavana Agrawal Resigns As CFO
21/07/2026 05:37
BRIEF-Astrazeneca Pharma Says Bhavana Agrawal Resigns As CFO July 21 (Reuters) - Astrazeneca Pharma India Ltd ASTR.NS:
ASTRAZENECA PHARMA INDIA - BHAVANA AGRAWAL RESIGNS AS CFO EFFECTIVE AUGUST 31, 2026
Source text: ID:nBSEbZMPhT
Further company coverage: ASTR.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma India Receives Permission To Import And Sell Trastuzumab Deruxtecan For Additional Indication
Brief: Astrazeneca Pharma Says Bhavana Agrawal Resigns As CFO
Brief: Astrazeneca Pharma India Receives Permission To Import And Sell Benralizumab For Additional Indication
Brief: Astrazeneca Pharma India Receives Permission To Import Benralizumab (Fasenra) For Additional Indication
Brief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan